Trial Details
COMPLETEDBasic Information
| Clinical ID | c1208 |
|---|---|
| Identifier | NCT00347048 |
| Trial Title | Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: tacrolimus|DRUG: Placebo |
Participant Information
| Sponsor | Astellas Pharma Inc |
|---|---|
| City | Chubu region |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-09-06 |
|---|---|
| Primary Completion Date | 2025-04-08 |
| Completion Date | 2025-04-08 |